NCT00000104
- Conditions
- Chemically-Induced Disorders, Heavy Metal Poisoning, Lead Poisoning, +1 more
- Locations
-
- Department of Neurology 420 Delaware St. SE, Box 486 Mayo Minneapolis, Minnesota, United States
Clinical trial condition
Poisoning
Explore clinical trials studying Poisoning. Study availability and eligibility vary by location and protocol.
577 public trials
72 recruiting studies
Poisoning trial results
Completed
Randomized Study of Succimer (Dimercaptosuccinic Acid) on Growth of Lead-Poisoned Children
NCT00004838
- Conditions
- Chemically-Induced Disorders, Disease Attributes, Heavy Metal Poisoning, +5 more
- Locations
-
Not specified
Active, Not Recruiting
Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer
NCT01949662
- Conditions
- Advanced Cancers, Chemically-Induced Disorders, Confusion, +15 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
ROBUST III- Re-Establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease
NCT03499964
- Conditions
- Bites and Stings, Chemically-Induced Disorders, Female Urogenital Diseases, +13 more
- Locations
-
- Academic Urology and Urogynecology of Arizona Phoenix, Arizona, United States
- Arkansas Urology Little Rock, Arkansas, United States
- Advanced Urology Institute Daytona Beach, Florida, United States
- University of Iowa Iowa City, Iowa, United States
Active, Not Recruiting
Proximal Spread in Adductor Canal Block(ACB)
NCT07595471
- Conditions
- Bites and Stings, Chemically-Induced Disorders, Neurologic Manifestations, +10 more
- Locations
-
- Ankara Etlik City Hospital Ankara, Turkey (Türkiye)
Active, Not Recruiting
Strong Heart Water Study
NCT03725592
- Conditions
- Arsenic Poisoning, Chemically-Induced Disorders, Heavy Metal Poisoning, Nervous System, +3 more
- Locations
-
- Johns Hopkins Bloomberg School of Public Health, ICTR Baltimore, Maryland, United States
Active, Not Recruiting
To Study the Individual Variants of Chemotherapy-Induced Neurotoxicity
NCT02481336
- Conditions
- Chemically-Induced Disorders, Nervous System Diseases, Neuromuscular Diseases, +3 more
- Locations
-
- National Cheng Kung University Hospital Tainan, Taiwan
Active, Not Recruiting
First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
NCT05361395
- Conditions
- Bites and Stings, Chemically-Induced Disorders, Extensive Stage Small Cell Lung Cancer, +9 more
- Locations
-
- University of Southern California, Norris Comprehensive Cancer Center Los Angeles, California, United States
- Christiana Care Health Services Newark, Delaware, United States
- Henry Ford Health System Detroit, Michigan, United States
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
Active, Not Recruiting
COMPASSION S3 Post-Approval Study
NCT04860765
- Conditions
- Bites and Stings, Cardiovascular Diseases, Chemically-Induced Disorders, +9 more
- Locations
-
- University of Alabama Birmingham, Alabama, United States
- Cedars Sinai Los Angeles, California, United States
- Children's Hospital of Colorado Aurora, Colorado, United States
- Advocate Childrens Hospital Oak Lawn, Illinois, United States
Active, Not Recruiting
Design of a Multicomponent Intervention to Reduce the Risk of Exposure Fluorine
NCT07232888
- Conditions
- Adherence Interventions, Behavior, Chemically-Induced Disorders, +18 more
- Locations
-
- Claudia García-Rojas Neiva, Colombia